Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Moldiag Diseases Genes Support Contact

Pseudohypoaldosteronism type1

Pseudohypoaldosteronism type 1 is a salt wasting disorder with elevated plasma aldosterone and renin levels. Inheritance may be autosomal recessive or dominant.

Clinical Findings

As all types of pseudohypoaldosteronism metabolic acidosis and hyperkalemia are present. Additionally, elevated levels of renin and aldosterone are mandatory. Blood pressure is rather low. Dependent on what molecular structure is altered, autosomal recessive (aldosteronsensitive sodium channel) or dominant (mineralocorticoid receptor) inheritance ensues.<br>Therapy consists of life-long salt supplementation in cases due to non-functioning sodium channel. Cases with mineralocorticoid receptor mutation tend to remission in adulthood.


The diagnosis of pseudohypoaldosteronism type 1 is likely when metabolic acidosis, and hyperkalemia are associated with elevated levels of aldosterone and renin. Additional findings are hypochloremia, hyponatremia, and a rather low blood pressure.<br> The type of inheritance is often difficult to determine, for most cases are spontaneous.


The main pathogenetic mechanisms are salt wasting and unresponsiveness to aldosterone. Disturbances in two molecular structures are responsible for the disease, the aldosterone-sensitive sodium channel, which is coded by three different genes, and the mineralocorticoid receptor.


Pseudohypoaldosteronism type 2
Pseudohypoaldosteronism type1



None (2003) Mendelian forms of human hypertension and mechanisms of disease.

external link

None (2005) Mineralocorticoid resistance.

external link

Orphanet article

Orphanet ID 756 external link

OMIM.ORG article

Omim 177735 external link
Update: Aug. 14, 2020
Copyright © 2005-2021 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944
Sitemap | Webmail | Disclaimer | Privacy Issues